GEODE CAPITAL MANAGEMENT, LLC
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 1214717
BOSTON, MA
Position in HRMY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$52,526,849
+$15,477,463 QoQ
Shares Held
1,442,649
+9.1% QoQ
Ownership
2.48%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 328 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. HRMY ranks #77 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in HRMY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,526,849 | 1,442,649 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $37,049,386 | 1,322,720 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $47,545,327 | 1,270,586 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $34,677,727 | 1,258,263 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $33,317,396 | 1,054,348 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $32,053,242 | 965,750 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $31,069,958 | 902,934 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $29,416,720 | 735,418 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $22,588,369 | 748,703 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $25,311,831 | 753,777 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $23,866,631 | 738,905 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $23,573,951 | 719,376 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $23,271,358 | 661,306 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $18,728,856 | 573,625 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $30,318,279 | 550,241 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $23,486,278 | 530,284 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $22,864,302 | 468,819 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $21,484,521 | 441,614 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $18,114,665 | 424,828 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $15,757,846 | 411,110 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $6,350,112 | 224,942 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,329,011 | 100,757 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $3,304,110 | 91,400 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,576,214 | 46,496 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||